1、Lan X, Liang J, Wen C, Quan X, Lin H, Xu Q, Chen P, Yao G, Zhou D, Yu M. Photo - manipulated polyunsaturated fatty acid - doped liposomal hydrogel for flexible photoimmunotherapy. Chinese Chemical Letters. 2024;35(4).DOI: 10.1016/j.cclet.2023.108616
2、Cui G, Deng S, Zhang B, Wang M, Lin Z, Lan X, Li Z, Yao G, Yu M, Yan J. Overcoming the Tumor Collagen Barriers: A Multistage Drug Delivery Strategy for DDR1-Mediated Resistant Colorectal Cancer Therapy. Adv Sci (Weinh). 2024 Sep;11(33):e2402107.
3、Xue X, Feng Q, Hong X, Lin Z, Luo Y, Li Y, Yao G, Wang N, Chen L. Comprehensive analysis of ALG3 in pan - cancer and validation of ALG3 as an onco - immunological biomarker in breast cancer. Aging (Albany NY). 2024 Feb 7;16(3):2320 – 2339
4、Ye L, Hou Y, Hu W, Wang H, Yang R, Zhang Q, Feng Q, Zheng X, Yao G, Hao H. Repressed Blautia-acetate immunological axis underlies breast cancer progression promoted by chronic stress. Nat Commun. 2023 Oct 3;14(1):6160. （共同通讯，IF=16.60）
5、Jiang W, Zhong S, Chen Z, Qian J, Huang X, Zhang H, Wen L, Zhang Y, Yao G. 2D-CuPd nanozyme overcome tamoxifen resistance in breast cancer by regulating the PI3K/AKT/mTOR pathway. Biomaterials. Biomaterials. 2023 Mar;294:121986.（通讯作者，IF=15.3）
6、Wang Z, Yu L, Wang Y, Wang C, Mu Q, Liu X, Yu M, Wang KN*, Yao G*, Yu Z*. Dynamic Adjust of Non-Radiative and Radiative Attenuation of AIE Molecules Reinforces NIR-II Imaging Mediated Photothermal Therapy and Immunotherapy. Adv Sci (Weinh). 2022 Jan 22:e2104793. （共同通讯，IF=17.521）
7、Cui G#, Wu J#, Lin J#, Liu W, Chen P, Yu M, Zhou D*, Yao G*. Graphene-based nanomaterials for breast cancer treatment: promising therapeutic strategies. J Nanobiotechnology. 2021.19(1):211（通讯作者，IF2021=10.435）
8、Zhang Y, Huang X, Wang L, Cao C, Zhang H, Wei P, Ding H, Song Y, Chen Z, Qian J, Zhong S, Liu Z, Wang M, Zhang W, Jiang W, Zeng J, Yao G, Wen LP. Glutathionylation-dependent proteasomal degradation of wide-spectrum mutant p53 proteins by engineered zeolitic imidazolate framework-8. Biomaterials. 2021 Feb 14;271:120720. （共同通讯，IF=10.371）
9、Lang Rao, Shu-Kun Zhao, Churan Wen, Rui Tian, Lisen Lin, Bo C ai, Yue Sun, Fei Kang, Zhen Yang, Liangcan He, Jing Mu, Qian-Fang Meng, Guangyu Yao*, Ni Xie*, and Xiaoyuan Chen*. Activating Macrophage-Mediated Cancer Immunotherapy by Genetically Edited Nanoparticles. Advanced Materials. 2020 Nov;32(47):e2004853. （共同通讯，IF=27.398）
10、Qian JY, Zhang WB, Wei PF, Yao GY, Yi TX, Zhang H, Ding H, Huang XW, Wang MM, Song Y, Zhong SQ, Yang LJ, Gao JH, Zhou ZJ, Wen LP, Zhang, YJ. Enhancing chemotherapy of p53-mutated cancer through ubiquitination-dependent proteasomal degradation of mutant p53 proteins by engineered ZnFe-4 nanoparticles. Adv Funct Mater. 2020 Aug 17. （共同通讯，IF=16.836）
11、Ding H, Song Y, Huang X, Wang L, Luo S, Zhang H, Pan H, Jiang W, Qian J, Yao G, Wen L, Zhang Y. mTORC1-dependent TFEB nucleus translocation and pro-survival autophagy induced by zeolitic imidazolate framework-8. Biomater Sci. 2020 Jul 1. （共同通讯，IF=6.183）
12、Cui G, He P, Yu L, Wen C, Xie X, Yao G. Oxygen self-enriched nanoplatform combined with US imaging and chemo/photothermal therapy for breast cancer. Nanomedicine-Nanotechnology Biology and Medicine. 2020 Jun 18:102238. （通讯作者，IF=5.182）